Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

Angela L. McCleary-Wheeler, Ryan M. Carr, Shanique R. Palmer, Thomas C. Smyrk, Jacob B. Allred, Luciana L. Almada, Ezequiel J. Tolosa, Maria J. Lamberti, David L. Marks, Mitesh J. Borad, Julian R. Molina, Yingwei Qi, Wilma L. Lingle, Axel Grothey, Henry C. Pitot, Aminah Jatoi, Donald W. Northfelt, Alan H. Bryce, Robert R. McWilliams, Scott H. OkunoPaul Haluska, George P. Kim, Gerardo Colon-Otero, Val J. Lowe, Matthew R. Callstrom, Wen We Ma, Tanios Bekaii-Saab, Mien Chie Hung, Charles Erlichman, Martin E. Fernandez-Zapico

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences